Summary
The monoclonal antibody MAb KI 67 reacts with a nuclear antigen throughout the entire cell cycle and allows easy evaluation of proliferating tumour cells on routinely prepared smear and frozen sections. 120 pituitary adenomas were investigated by use of the monoclonal antibody KI 67 in a two-step avidin-biotin-peroxidase complex (ABC) technique. The KI 67 labelling index (LI) ranged in all adenomas from 0.2 to 4.6%. In 90 cases of transphenoidally operated adenomas the dura of the sella floor was investigated histologically. Adenomas with histologically proven dural infiltration showed a statistically significant higher KI 67 LI (p < 0.001) compared to non-invasive adenomas.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ciric I, Mikhael M, Stanford T, Lawson L (1983) Transsphenoidal microsurgery of pituitary macroadenomas with long term follow up results. J Neurosurg 59: 395–402
Cooper EH, Frank GL, Wright DH (1966) Cell proliferation in Burkitt tumors. Europ J Cancer 2: 377–384
Ebershold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV (1986) Long term results in transsphenoidal removal of non functioning pituitary adenomas. J Neurosurg 64: 713–719
Fahlbusch R, Buchfelder M, Schreu K (1987) Short time preoperative treatment of macroprolactinomas by dopamine agonists. J Neurosurg 67: 807–815
Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20
Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by monoclonal antibody KI 67. J Immunol 113: 1710–1715
Goz B (1977) The effects of incorporation of 5 halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmakol Rev 29: 247–272
Gratzner HG (1982) Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 218: 474–475
Guesdon JL, Ternynck T, Avrameas S (1979) The use of avidinbiotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27: 1131–1139
Hardy J (1969) Transsphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 16: 185–217
Hardy J (1983) Transsphenoidal microsurgery of prolactinomas: Report of 355 cases. In: Tolis G, Stefanis C, Mountokalakis T (eds) Prolactin and prolactinomas. Raven Press, New York, pp 431–440
Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W (1980) Silent corticotropic adenomas of the human pituitary gland: A histopathologic immunocytologic and ultra-structural study. Am J Pathol 98: 617–638
Horvath E, Kovacs K, Singer W, Ezrin C, Kerenyi A (1977) Acidophil stemcell adenoma of the human pituitary. Arch Pathol Lab Med 101: 594–599
Hoshino T, Nagashima T, Murovic JA (1986) In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxy- uridine labeling. J Neurosurg 64: 453–459
Hsu SM, Raine L, Fanger H (1981) Use of Avidine-Biotin- Peroxidase Complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 577–580
Hubbard JL, Scheithauer BW, Abboud CHF, Laws ER (1967) Prolactin secreting adenomas: The preoperative response to bromocriptine treatment and surgical outcome. J Neurosurg 67: 816–821
Johnson HA, Haymaker WE, Rubini JR (1960) A radioauto- graphic study of a human brain and glioblastoma multiforme after in vivo uptake of tritiated thymidine. Cancer 13: 636–642
Knosp E, Krisch K, Schmidbauer M, Budka H (1988) Immunologischer Hormonnachweis bei Hypophysenadenomen: Korrelation von Serumhormonbefunden mit immunzyto- chemischem Hormonbefund am Tumorschnitt. Wien Klin Wochenschr 100: 322–325
Knosp E, Kitz K, Perneczky A (1989) Proliferation activity in pituitary adenomas: Measurement by monoclonal antibody KI 67. Neurosurg 25: 927–930
Kovacs K (1984) Light and electron microscopic pathology of pituitary tumors: Immunohistochemistry. In: Black McL, Zervas NT, Ridgeway EC, Martin JB (eds) Secretory tumors of the pituitary gland. Raven Press, New York, pp 365–375
Landolt AM (1980) Biology of pituitary microadenomas. In: Faglia G, Giovanelli MA, Mac Leod RM (eds) Pituitary microadenomas. Academic Press, London, pp 107–122
Landolt AM, Shibata T, Kleihues P (1987) Growth rate of human pituitary adenomas. J Neurosurg 67: 803–806
Landolt AM, Shibata T, Kleihues P, Tuncdogan E (1988) Growth of pituitary adenomas: Facts and speculations. Adv Biosciences 69: 53–62
Laws ER, Piepgras DG, Rendali RV (1979) Neurosurgical management of acromegaly: Results in 82 patients treated between 1972–1977. J Neurosurg 50: 454–461
Laws ER (1984) The Neurosurgical management of acromegaly. In: Black McL, Zervas NT, Ridgeway EC, Martin JB (eds) Secretory tumors of the pituitary gland. Raven Press, New York, pp 169–173
Martins AN, Hayes GJ, Kempe LG (1985) Invasive pituitary adenomas. J Neurosurg 22: 268–276
Morimura T, Kitz K, Budka H (1989) In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S-phase cells by a new in vitro BrdU labeling technique and of proliferating pool cells by monoclonal antibody KI 67. Acta Neuropathol (Beri) 77: 276–282
Nagashima T, Murovic JA, Hoshino T, Wilson CB, Dearmond SJ (1986) The proliferative potential of human pituitary tumours in situ. J Neurosurg 64: 588–594
Nagashima T, Hoshino T, Cho KG, Senegor M, Waldman F, Nomura K (1988) Comparison of bromodesoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumours. J Neurosurg 68: 388–392
Naritoku WY, Taylor CR (1982) A comparative study of the use of monoclonal antibodies using three different immunohistochemical methods: An evaluation of monoclonal and polyclonal antibodies against human prostatic acid phosphatase. J Histochem Cytochem 30: 253–260
Nishizaki T, Orita T, Saiki M, Furutani Y, Aoki H (1988) Cell kinetic studies of human brain tumors by in vitro labeling using anti BrdU monoclonal antibody. J Neurosurg 69: 371–374
Ross DA, Wilson CB (1988) Results of transsphenoidal microsurgery for growth hormone secreting pituitary adenomas in a series of 214 patients. J Neurosurg 68: 854–867
Seager W (1977) Die Hypophysentumore: Zytologische und ultrastrukturelle Klassifikation, Pathogenese, endokrine Funktionen und Tierexperimente. Fischer G, Stuttgart New York, pp 39–42
Selman WR, Laws ER, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64: 402–408
Scheithauer BW, Kovacs KT, Laws ER, Randall RV (1986) Pathology in invasive pituitary tumors with special reference to functional classification. J Neurosurg 65: 733–745
Tindall GT, Tindall SC (1984) Transsphenoidal surgery for acromegaly; Long term results in 50 patients. In: Black McL, Zervas NT, Ridgeway EC, Martin JB (eds) Secretory tumors of the pituitary gland. Raven Press, New York, pp 175–178
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag
About this paper
Cite this paper
Kitz, K., Knosp, E., Koos, W.T., Korn, A. (1991). Proliferation in Pituitary Adenomas: Measurement by MAb KI 67. In: Koos, W., Richling, B. (eds) Processes of the Cranial Midline. Acta Neurochirurgica Supplementum, vol 53. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9183-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9183-5_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-9185-9
Online ISBN: 978-3-7091-9183-5
eBook Packages: Springer Book Archive